Form 4 for TLSI TriSalus Life Sciences, Inc.
Accepted 2024-09-10 00:00:00 ET · period of report 2024-08-28 · accession 0001415889-24-023167 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2024-09-10 | 2024-08-28 | TLSI | Martin George Kelly | Dir | S - Sale | $5.50 | -9 | 247.2K | -0.0% | -$49.50 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-08-28 | S | D | 9 | $5.50 | 247,176 | I By Varka LLC | — | — | (F1) The shares are held by Varka LLC. The Reporting Person may be deemed to have beneficial ownership of the shares held directly by Varka LLC. |